News Focus
News Focus
icon url

Viewmont

11/09/24 5:26 PM

#49467 RE: TMaga #49466

$ADHC has no such issue!!! Why posting non existent bullshiit on all boards, working hard to create chaos? Stop it!

$ADHC
Bullish
Bullish
icon url

Viewmont

11/09/24 5:47 PM

#49469 RE: TMaga #49466

Transforming Diabetes Management
Zachary Smith commented, "ADHC provides the ideal platform for the commercialization of GlucoGuard. Both Bill and I are eager to bring this life-saving technology to market, helping millions of diabetic patients-both adults and children-better manage their glucose levels with greater safety and ease."

Bill Colone added, "Hypoglycemia, particularly during sleep, is a persistent and dangerous issue for diabetic patients, often leading to serious consequences like the dreaded 'Death in Bed' syndrome. GlucoGuard's technology offers a game-changing solution to this pressing problem."

Key Development Partnerships
The GlucoGuard system is being developed in collaboration with three key partners:

A leading U.S. research university.
A highly respected biomedical and defense engineering firm.
A top publicly traded company in the Continuous Glucose Monitoring (CGM) sector.
Further details on these collaborations will be disclosed soon.

Cutting-Edge Technology for Unmet Medical Needs
GlucoGuard combines advanced engineering, artificial intelligence (AI), and mobile app-based monitoring to create an innovative solution for managing nocturnal Hypoglycemia. The GlucoGuard mouthpiece continuously monitors glucose levels during sleep and automatically administers glucose when hypoglycemic levels are detected. Sophisticated AI algorithms facilitate this process, ensuring effective glucose management without disturbing the patient's rest.

"The GlucoGuard invention is a significant leap forward in addressing one of the most dangerous complications of diabetes," said ADHC management. "We are thrilled to welcome Zachary Smith and his innovative team to ADHC, and we're committed to fast-tracking the development and commercialization of this much-needed technology."

About Artificial Intelligence and Health Care
A recent report from the Mayo Clinic identified three potential benefits of AI in healthcare:

Improving outcomes for both patients and clinical teams.
Lowering healthcare costs.
Benefitting population health.
From preventive screenings to diagnosis and treatment, AI is being used throughout the continuum of care today. Two examples are Preventive Health Care and Risk Assessment.

Cancer Screenings that use radiology can leverage AI to help produce results faster. A noted example is analyzing kidney images in a laborious 45 minute process. AI automated process can reduce this analysis to minutes, saving time, money and giving a more accurate diagnosis.

Pre-diabetes patients with no notable symptoms can be screened using AI to determine which type of diabetes they are at risk for and begin preventative care.

See AI in healthcare: The future of patient care and health management - Mayo Clinic Press.

About the Diabetes Market
The diabetes market is poised for substantial growth, with the U.S. market valued at $28 billion, underscoring the vast potential for GlucoGuard's adoption.

For more information on the $28 billion diabetes market, visit: United States Diabetes Market Report.

The Continuous Glucose Monitoring (CGM) sector, valued at $6.8 billion, further emphasizes the critical demand for advanced glucose management solutions.

For details on the CGM market, visit: Continuous Glucose Monitoring Market.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7822/224435_0235dd85640e0901_001full.jpg

Image 1

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/224435_0235dd85640e0901_001full.jpg


About IMD Solutions, Inc.
IMD Solutions, Inc. is a Nevada-based medical device company developing GlucoGuard, a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of low blood sugar during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, IMD Solutions is at the forefront of diabetes management technology.

For more information, visit: www.GlucoGuardSleep.com.
Contact: Phone: 817-525-0057
Email: info@GlucoGuardSleep.com

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7822/224435_0235dd85640e0901_002full.jpg

Image 2

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/224435_0235dd85640e0901_002full.jpg


About AMERICAN DIVERSIFIED HOLDINGS CORPORATION
www.UniversalWellnessAI.com
www.UniversalWellnessShop.com

John Cacchioli, CEO
American Diversified Holdings Corporation
Telephone: (212) 537-5900
Email: JC@American-Diversified.com

Social Media:
TWITTER: @ADHCManagement.
This Twitter page is the only official Twitter page for ADHC.
Bullish
Bullish
icon url

Viewmont

11/09/24 5:51 PM

#49470 RE: TMaga #49466

@ADHCMANAGEMENT
$ADHC
Hello I am Zachary Smith , founder of Glucoguard, We are prepping a series of videos for You Tube explaining the Glucoguard technology with a focus on how AI & CGM manages diabetes. Focus is On IR, PR and Patient Advocacy creating global awareness.
icon url

Viewmont

11/09/24 5:54 PM

#49471 RE: TMaga #49466

@ADHCMANAGEMENT
$ADHC
Hello I am Zachary Smith , founder of Glucoguard, We are prepping a series of videos for You Tube explaining the Glucoguard technology with a focus on how AI & CGM manages diabetes. Focus is On IR, PR and Patient Advocacy creating global awareness.
Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration
Press Release | 10/29/2024
Del Mar, California--(Newsfile Corp. - October 29, 2024) - American Diversified Holdings Corporation (OTC Pink: ADHC) announced today that Glucoguard, has competed the "MADO" Mobile Application and Design Outline as required for the Dexcom API Integration.

This outline has been submitted to the software design team to finalize the integration process through the Dexcom Development Partner Program.

The proprietary AI based algorithm outlined in the MADO is the backbone of the Glucoguard App and the foundation for the diabetes management system. The main AI component analyzes current blood sugar levels and will predictively treat lows before a potential catastrophic hypoglycemic event can occur.

Glucoguard is developing a mobile application to enable and support the functionality of the patent-pending diabetes management system. The system integrates with Dexcom's Continuous Glucose Monitoring (CGM) technology to track blood glucose levels and then respond to fluctuations in real-time, as a preemptive solution to the potential catastrophic effects of hypoglycemia.

The mobile app will serve as an essential tool for users, connecting them directly to the Glucoguard device. The device provides glucose to patients when the AI-based Algorithm detects critical changes in glucose levels, preventing dangerous episodes of Hypoglycemia (low blood sugar). By using a state-of-the-art Artificial Intelligence algorithm to ensure Glucoguard offers a best-in-class approach to diabetes management.

"Events are moving rapidly with the Glucoguard Team. Once the full API integration process is complete, we will move to prototype development and full software/hardware integration," commented Glucoguard/ADHC. "Glucoguard will soon be on the map in the diabetes management sector, utilizing AI to elevate Continuous Glucose Management to the next level treatment of diabetic patients."

Shareholders will be notified as developments are finalized in the near future.

About IMD Solutions, Inc.
IMD Solutions, Inc. is a Nevada-based medical device company developing GlucoGuard, a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of low blood sugar during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, IMD Solutions is at the forefront of diabetes management technology.

For more information, visit: www.GlucoGuardSleep.com.
Contact: Phone: 817-525-0057
Email: info@GlucoGuardSleep.com

About AMERICAN DIVERSIFIED HOLDINGS CORPORATION
www.UniversalWellnessAI.com
www.UniversalWellnessShop.com

John Cacchioli, CEO
American Diversified Holdings Corporation
Telephone: (212) 537-5900
Email: JC@American-Diversified.com

Social Media:
TWITTER: @ADHCManagement.
This Twitter page is the only official Twitter page for ADHC.
icon url

Viewmont

11/09/24 8:59 PM

#49476 RE: TMaga #49466

Fines or imprisonment
Stock bashers who knowingly post false information to drive down stock prices can face legal consequences such as fines or imprisonment134. Regulatory bodies actively monitor and investigate cases of market manipulation to maintain market integrity3.

Stock Bashing: Understanding Market Manipulation and Its Implications
Regulators and law enforcement agencies closely monitor and investigate instances of market manipulation to maintain market integrity and protect investors from fraudulent activities.
Abi Bus
Last updated 04/16/2024 by

Abi Bus
Edited by

Alec Grabata
Fact checked by

Ante Mazalin
Summary:
Stock bashers manipulate the market by spreading false information to drive down stock prices, often targeting smaller companies. This illegal practice can result in fines and prosecution, impacting investor confidence and market integrity.
Regulators and law enforcement agencies closely monitor and investigate instances of market manipulation to maintain market integrity and protect investors from fraudulent activities.

Understanding stock bashers
A stock basher, also known as a short seller or market manipulator, is an individual or group that engages in illegal activities to profit from the decline in the price of a particular stock. Stock bashers typically target small-cap or penny stocks that have low liquidity and limited market information, making them more susceptible to manipulation. These individuals spread false or misleading information about the targeted stock, often through online forums, social media platforms, or financial news outlets, with the goal of inducing panic selling among investors.
Motivations behind stock bashing
Stock bashers have various motivations for engaging in market manipulation. One common motivation is financial gain through short selling. Short sellers borrow shares of a stock and sell them with the expectation that the stock price will decrease, allowing them to buy back the shares at a lower price and return them to the lender, pocketing the difference as profit. By spreading negative rumors or false information about a stock, stock bashers aim to drive down its price, enabling them to profit from their short positions.
Another motivation for stock bashing may be revenge or personal vendettas against a company or its management. Former employees, disgruntled stakeholders, or competitors may seek to discredit a company by spreading false information to damage its reputation and stock price. In some cases, stock bashers may have ideological or political agendas and use market manipulation as a means to advance their interests or agendas.
Methods of market manipulation
Stock bashers employ a variety of tactics to manipulate the market and drive down stock prices. These tactics may include spreading false rumors, making baseless accusations, or distorting facts to create negative sentiment among investors. Stock bashers often use social media platforms, online forums, and financial news websites to disseminate their misinformation to a wide audience.
In addition to spreading false information, stock bashers may engage in coordinated trading activities to manipulate stock prices. This may involve placing large sell orders to create the illusion of high selling pressure, driving down the price of the targeted stock. Stock bashers may also collaborate with other individuals or groups to amplify their impact on the market, making it more difficult for regulators to detect and prevent their activities.
Impact on investors and the market
The activities of stock bashers can have significant consequences for investors and the broader financial markets. False or misleading information spread by stock bashers can erode investor confidence, leading to panic selling and increased market volatility. This can result in financial losses for individual investors who are misled by the misinformation and sell their shares at artificially low prices.
In addition to harming individual investors, stock bashing undermines the integrity and efficiency of the financial markets. Market manipulation distorts stock prices, making it difficult for investors to make informed investment decisions based on accurate information. Regulators and law enforcement agencies closely monitor and investigate instances of market manipulation to maintain market integrity and protect investors from fraudulent activities.